OSCR
Oscar Health, Inc.
OSCR has the edge over PANW overall, supported by stronger modeled upside and stronger valuation.
PANW
Palo Alto Networks, Inc.
PANW trails on the overall score without a compensating advantage in the available component scores.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
PANW Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Strong |
PANW's revenue, cash flow and balance sheet are currently strong, and its profitability is stable.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over PANW in the historical PE scenario, which offers more potential upside but is not a forecast.
PANW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 48x | $19.37 | -94% |
| Forward | 74x | $323 | — |
| Fair | 117x | $46.90 | -85% |
| Expensive | 344x | $138 | -57% |
| Current | 807x | $323 | — |
Historical ranges are pointers, not guarantees.
PANW's PE is in its expensive range at 807x. If earnings grow as analysts expect, today's price would be 74x next year's earnings, in its cheap range.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OSCR has the edge over PANW on the outlook, with more favorable profitability expectations.
PANW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Weakening | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for PANW, but weaker profitability.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over PANW on earnings, with more consistent year-over-year improvement.
PANW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.34 | +985% |
| Q3 2026 | $0.40 | -75% |
| Q2 2026 | $1.21 | -32% |
| Q1 2026 | $1.80 | +0.6% |
| Q4 2025 | $1.57 | -59% |
| Q3 2025 | $1.60 | -56% |
| Q2 2025 | $1.77 | -49% |
| Q1 2025 | $1.79 | -44% |
| Q4 2024 | $3.85 | +333% |
PANW's earnings per share have fallen from their peak: $0.40 over the past year, against $3.85 in late 2024.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over PANW on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
PANW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.4B | +34% |
| Q2 2026 | $3B | +31% |
| Q1 2026 | $2.6B | +15% |
| Q4 2025 | $2.5B | +16% |
| Q3 2025 | $2.5B | +16% |
| Q2 2025 | $2.3B | +15% |
| Q1 2025 | $2.3B | +14% |
| Q4 2024 | $2.1B | +14% |
PANW's revenue has grown year over year every quarter since late 2020: $3.4B last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5% | -15 points |
| Q2 2026 | -6.1% | -16 points |
| Q1 2026 | 15% | +4.7 points |
| Q4 2025 | 12% | -0.9 points |
| Q3 2025 | 20% | +8.7 points |
| Q2 2025 | 9.6% | +0.7 points |
| Q1 2025 | 11% | +7.9 points |
| Q4 2024 | 13% | +1.9 points |
PANW has the edge over OSCR on profitability, with a higher operating margin.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over PANW on cash flow, with more consistent year-over-year improvement.
PANW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +34% |
| Q2 2026 | $788M | +41% |
| Q1 2026 | $384M | -25% |
| Q4 2025 | $1.7B | +15% |
| Q3 2025 | $934.5M | +101% |
| Q2 2025 | $560.4M | +14% |
| Q1 2025 | $509.4M | -22% |
| Q4 2024 | $1.5B | -1.6% |
PANW's free cash flow has been positive every quarter for seven years: $4.1B over the past year, up 19% from the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PANW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.6% | -37M shares |
| 1 year | +7.7% | +54.7M shares |
| 3 years | +12% | +79.4M shares |
| 5 years | +32% | +186M shares |
| Available history | +32% | +184M shares |
PANW has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $500M |
| Q1 2024 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over PANW on leverage, with a lower net debt burden relative to earnings.
PANW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.6x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -2.3x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.2x | Net Cash |
PANW has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
PANW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 18.8 | Oversold |
PANW's weekly RSI is 50 (neutral) and its Stochastic is 19 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over PANW on valuation relative to its sector.
PANW PE vs Technology Sector
| Metric | PANW | Sector median | Relative |
|---|---|---|---|
| PE | 807x | 28x | 2,795% above |
| PE % | 89 | 35 | 54 pts above |
PANW is trading at 807x earnings, a 2795% premium to the Technology sector's median of 28x.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over PANW on trend strength, trading above more of its moving averages.
PANW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $365.2 | 12% below |
| 20 week MA | $355.8 | 9.3% below |
| 50 week MA | $260.9 | 24% above |
| 100 week MA | $225.6 | 43% above |
| 200 week MA | $182.3 | 77% above |
PANW has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 77% above its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over PANW on returns for 2026, with the stronger performance.
PANW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.9 | $61.2 | +57% |
| 2021 | $61.2 | $93.6 | +53% |
| 2022 | $93.6 | $70.6 | -25% |
| 2023 | $70.6 | $147.4 | +109% |
| 2024 | $147.4 | $186.2 | +26% |
| 2025 | $186.2 | $188.5 | +1.2% |
| 2026 YTD | $188.5 | $322.7 | +71% |
PANW has finished higher in five of the last six years, three of them by more than 50%. It's up 71% so far in 2026.